Table 3 Pathological manifestations of patients in this study
Anti-SRP IMNM-SS (n = 6) | Anti-SRP IMNM (n = 24) | P value | ||
|---|---|---|---|---|
CD4 (cell count > 5) | Total | 6(100) | 13(54.2) | 0.013 |
Necrosis | 4(66.7) | 4(16.7) | 0.023 | |
Endomysial | 5(83.3) | 7(29.2) | 0.013 | |
Perimysial | 0 | 0 | 0.108 | |
Perivascular | 0 | 0 | 0.219 | |
CD8 (cell count > 5) | Total | 2(33.3) | 6(25) | 0.614 |
Necrosis | 3(50) | 1(4.2) | 0.355 | |
Endomysial | 0 | 1(4.2) | 0.573 | |
Perimysial | 0 | 0 | 0.421 | |
Perivascular | 0 | 0 | 0.268 | |
CD20 (cell count > 5) | Total | 3(50) | 1(4.2) | 0.176 |
Necrosis | 2(33.3) | 0 | 0.123 | |
Endomysial | 0 | 0 | 0.7 | |
Perimysial | 0 | 0 | 0.387 | |
Perivascular | 0 | 0 | > 0.9999 | |
CD68 (cell count > 5) | Total | 6(100) | 12(50) | 0.046 |
Necrosis | 4(66.7) | 8(33.3) | 0.176 | |
Endomysial | 2(33.3) | 2(8.3) | 0.016 | |
Perimysial | 0 | 0 | 0.295 | |
Perivascular | 0 | 0 | 0.614 | |
MHC(Grading Scales) | Sarcolemmal/Sarcoplasmic staining | 5(83.3) | 18(75) | 0.387 |
MAC(Grading Scales) | Sarcolemmal | 5(83.3) | 4(16.7) | 0.013 |
Sarcoplasm | 3(50) | 9(37.5) | > 0.9999 | |
Capillary | 3(50) | 2(8.3) | 0.176 | |